Guangzhou Jointas Chemical Co., Ltd. (SHE:002909)
China · Delayed Price · Currency is CNY 7.73
+0.08 (1.05%)
Feb 27, 2026, 3:04 PM CST
SHE:002909 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,163 | 1,282 | 1,328 | 1,447 | 1,674 | 1,257 |
Other Revenue | 3.05 | 3.05 | 3.92 | 3.59 | 1.56 | 1.42 |
| 1,166 | 1,285 | 1,332 | 1,450 | 1,676 | 1,259 | |
Revenue Growth (YoY) | -8.60% | -3.56% | -8.13% | -13.44% | 33.12% | 23.88% |
Cost of Revenue | 874.4 | 962.42 | 999.44 | 1,139 | 1,324 | 868.41 |
Gross Profit | 291.84 | 322.49 | 332.96 | 311.27 | 351.55 | 390.3 |
Selling, General & Admin | 198.62 | 199.83 | 219.44 | 198.6 | 202.94 | 172.13 |
Research & Development | 49.89 | 59.3 | 65.02 | 60.56 | 68.87 | 52.95 |
Other Operating Expenses | 7.95 | 4.65 | 2.11 | 8.46 | 8.34 | 7.8 |
Operating Expenses | 271.8 | 282.16 | 294.73 | 285.98 | 293.88 | 243.72 |
Operating Income | 20.04 | 40.33 | 38.23 | 25.29 | 57.68 | 146.57 |
Interest Expense | -26.15 | -28.46 | -29.17 | -24.82 | -16.47 | -13.31 |
Interest & Investment Income | - | 0.88 | 1.74 | 2.88 | 4.78 | 2.98 |
Currency Exchange Gain (Loss) | 0.11 | 0.11 | 0.16 | 0.78 | 0.12 | -0.1 |
Other Non Operating Income (Expenses) | -1.07 | -1.37 | -0.85 | -0.84 | -1.34 | -0.06 |
EBT Excluding Unusual Items | -7.07 | 11.48 | 10.11 | 3.29 | 44.77 | 136.08 |
Gain (Loss) on Sale of Investments | -0.76 | -0.62 | - | 3.08 | - | -0.64 |
Gain (Loss) on Sale of Assets | 0.04 | 0.1 | 0.1 | 0.06 | -0.96 | -0.01 |
Asset Writedown | -0.36 | -2.34 | -0.49 | -0.8 | -0.49 | -2.29 |
Other Unusual Items | 3.94 | 3.94 | 1.43 | 5.98 | 10.5 | 3.27 |
Pretax Income | -4.22 | 12.56 | 11.15 | 11.61 | 53.82 | 136.41 |
Income Tax Expense | -4.41 | -6.71 | 0.9 | 1.41 | 3.12 | 23.65 |
Earnings From Continuing Operations | 0.19 | 19.27 | 10.25 | 10.2 | 50.7 | 112.77 |
Minority Interest in Earnings | 0.35 | 0.01 | -0.01 | -0 | -0.01 | -1.01 |
Net Income | 0.54 | 19.28 | 10.24 | 10.19 | 50.69 | 111.75 |
Net Income to Common | 0.54 | 19.28 | 10.24 | 10.19 | 50.69 | 111.75 |
Net Income Growth | -93.09% | 88.27% | 0.49% | -79.90% | -54.64% | 30.83% |
Shares Outstanding (Basic) | 390 | 393 | 379 | 377 | 373 | 327 |
Shares Outstanding (Diluted) | 390 | 393 | 379 | 377 | 373 | 327 |
Shares Change (YoY) | 2.71% | 3.74% | 0.49% | 1.27% | 14.06% | -0.46% |
EPS (Basic) | 0.00 | 0.05 | 0.03 | 0.03 | 0.14 | 0.34 |
EPS (Diluted) | 0.00 | 0.05 | 0.03 | 0.03 | 0.14 | 0.34 |
EPS Growth | -93.27% | 81.48% | - | -80.15% | -60.23% | 31.44% |
Free Cash Flow | 27.38 | 90.82 | -11.52 | -304.09 | -113.21 | -66.24 |
Free Cash Flow Per Share | 0.07 | 0.23 | -0.03 | -0.81 | -0.30 | -0.20 |
Dividend Per Share | 0.100 | 0.100 | 0.050 | 0.050 | 0.050 | 0.107 |
Dividend Growth | 100.00% | 100.00% | - | - | -53.31% | -30.05% |
Gross Margin | 25.02% | 25.10% | 24.99% | 21.46% | 20.98% | 31.01% |
Operating Margin | 1.72% | 3.14% | 2.87% | 1.74% | 3.44% | 11.64% |
Profit Margin | 0.05% | 1.50% | 0.77% | 0.70% | 3.02% | 8.88% |
Free Cash Flow Margin | 2.35% | 7.07% | -0.86% | -20.97% | -6.76% | -5.26% |
EBITDA | 78.56 | 97.11 | 92.68 | 69.58 | 92.44 | 173.18 |
EBITDA Margin | 6.74% | 7.56% | 6.96% | 4.80% | 5.52% | 13.76% |
D&A For EBITDA | 58.53 | 56.78 | 54.45 | 44.29 | 34.76 | 26.6 |
EBIT | 20.04 | 40.33 | 38.23 | 25.29 | 57.68 | 146.57 |
EBIT Margin | 1.72% | 3.14% | 2.87% | 1.74% | 3.44% | 11.64% |
Effective Tax Rate | - | - | 8.11% | 12.17% | 5.81% | 17.34% |
Revenue as Reported | 1,166 | 1,285 | 1,332 | 1,450 | 1,676 | 1,259 |
Advertising Expenses | - | 5.72 | 12.57 | 5.99 | 5.96 | 3.91 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.